What people are saying - Write a review
We haven't found any reviews in the usual places.
Doxorubicin HC1 Liposome Injection
Additions to Commercial Drug Monograph Tables
Parenteral Nutrition Mixture Formulas
Other editions - View all
0.25 mg/mlb Physically 2-in-l admixture 2087 c Remifentanil Amphotericin B cholesteryl besylate GW 0.1 bTested in sodium change in measured cholesteryl sulfate complex Cisatracurium besylate GW cle content Compatibility 1:1 Mixture compatible with little complex SEQ 0.83 composition of parenteral Cone Mfr Cone Cone Remarks Ref days at 25 Doxorubicin HC1 liposome Drug Mfr Cone fluorescent light 2117 Fosphenytoin Gross precipitate forms Handbook on Injectable HC1 liposome injection hr at 23 Hydromorphone increase in particle indicates a 2-in-l Injectable Drugs Injection Compatibility 1:1 injection SEQ 0.4 liposome injection SEQ loss by HPLC measured turbidity Metronidazole Mfr Cone Mfr Mfr Cone Remarks mg/ml mg/mlb Physically compatible Midazolam ondansetron paclitaxel parenteral nutrition parenteral nutrition solutions particle content phenytoin precipitate forms 2117 Ranitidine Ref C/I Amphotericin Refer to Appendix Remarks Ref C/I Remifentanil HC1 GW sodium chloride 0.9 sulfate complex SEQ Tested in dextrose TPN indicates turbidity or increase Warfarin YSite Injection Compatibility